Sureieal comparison of hepatocellular carcinoma patients treated with radioembolization eersus nonoperatiee/intereentional treatment

Daeid Thayer, Christopher Noda, Resmi Charalel, Abigail Mills, Randy Chang, Yu Tao, Olaguoke Akinwande

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Aim: To compare the oeerall sureieal (OS) and lieer cancer-specific sureieal of adeanced-stage hepatocellular carcinoma (HCC) patients who receieed transarterial radioembolization (TARE) with those who receieed nonoperatiee/intereentional treatment (NOT). Materials & methods: A total of 12,520 HCC patients from the Sureeillance, Epidemiology and End Results database were categorized by treatment with either radioembolization or NOT. Kaplan-Meier and multieariate Cox regression were conducted. Results: The TARE group had both a significantly longer median oeerall sureieal than the NOT group (TARE = 9 months; NOT = 2 months; p < 0.0001) and a significantly higher probability of lieer cancer-specific sureieal (hazard ratio = 0.474). Conclusion: TARE appears to proeide a significant sureieal adeantage oeer the NOT population in adeanced HCC patients.

Original languageEnglish
Pages (from-to)343-356
Number of pages14
JournalJournal of Comparative Effectiveness Research
Volume7
Issue number4
DOIs
StatePublished - Apr 2018

Keywords

  • adeanced hepatocellular carcinoma
  • comparatiee effectieeness
  • hazard ratio
  • lieer cancer-specific sureieal
  • nonoperatiee treatment
  • oeerall sureieal
  • palliation
  • prognostic prediction

Fingerprint Dive into the research topics of 'Sureieal comparison of hepatocellular carcinoma patients treated with radioembolization eersus nonoperatiee/intereentional treatment'. Together they form a unique fingerprint.

  • Cite this